Celularity Inc. (CELU)

NASDAQ: CELU · Real-Time Price · USD

0.8723

-0.1227 (-12.33%)

At close: Jun 5, 2026, 4:00 PM EDT

0.8630

-0.0093 (-1.07%)

After-hours: Jun 5, 2026, 7:26 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Cell Therapy	3.81M	688.00K	-	-	-
Cell Therapy Growth	453.34%	-	-	-	-
Biobanking	5.43M	5.14M	5.44M	5.51M	5.52M
Biobanking Growth	5.68%	-5.53%	-1.29%	-0.18%	-0.61%
Degenerative Disease	17.31M	48.39M	17.33M	12.46M	15.81M
Degenerative Disease Growth	-64.23%	179.24%	39.05%	-21.19%	81.30%
Total	26.55M	54.22M	22.77M	17.98M	21.34M
Total Growth	-51.03%	138.11%	26.68%	-15.75%	49.43%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States	26.55M	54.22M	22.77M	17.98M	21.34M
United States Growth	-51.03%	138.11%	26.68%	-15.75%	49.43%
Total	26.55M	54.22M	22.77M	17.98M	21.34M
Total Growth	-51.03%	138.11%	26.68%	-15.75%	49.43%

Source: S&P Global Market Intelligence.